BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15538952)

  • 21. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial.
    Brecht S; Desaiah D; Marechal ES; Santini AM; Podhorna J; Guelfi JD
    J Clin Psychiatry; 2011 Aug; 72(8):1086-94. PubMed ID: 20868642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome.
    Strik JJ; Lousberg R; Cheriex EC; Honig A
    J Psychosom Res; 2004 Jan; 56(1):59-66. PubMed ID: 14987965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depressive symptoms in patients with HIV infection: a further exploration.
    Judd F; Mijch A; McCausland J; Cockram A
    Aust N Z J Psychiatry; 1997 Dec; 31(6):862-8. PubMed ID: 9483260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression among people living with human immunodeficiency virus infection/acquired immunodeficiency syndrome in Benin City, Nigeria: a comparative study.
    Chikezie UE; Otakpor AN; Kuteyi OB; James BO
    Niger J Clin Pract; 2013; 16(2):238-42. PubMed ID: 23563469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study.
    Judd FK; Cockram AM; Komiti A; Mijch AM; Hoy J; Bell R
    Aust N Z J Psychiatry; 2000 Dec; 34(6):1015-21. PubMed ID: 11127611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring desire for death among patients with HIV/AIDS: the schedule of attitudes toward hastened death.
    Rosenfeld B; Breitbart W; Stein K; Funesti-Esch J; Kaim M; Krivo S; Galietta M
    Am J Psychiatry; 1999 Jan; 156(1):94-100. PubMed ID: 9892303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil.
    Kamat R; Morgan E; Marcotte TD; Badiee J; Maich I; Cherner M; de Almeida S; de Pereira AP; Ribeiro CE; Barbosa F; Atkinson JH; Ellis R;
    J Affect Disord; 2013 Sep; 150(3):1069-75. PubMed ID: 23245465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression in people living with HIV/AIDS attending primary care and outpatient clinics.
    Komiti A; Judd F; Grech P; Mijch A; Hoy J; Williams B; Street A; Lloyd JH
    Aust N Z J Psychiatry; 2003 Feb; 37(1):70-7. PubMed ID: 12534660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS.
    Kalichman SC; Rompa D; Cage M
    J Nerv Ment Dis; 2000 Oct; 188(10):662-70. PubMed ID: 11048815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of and risk factors for depressive symptoms among people living with HIV/AIDS receiving antiretroviral treatment in Wuhan, China: a short report.
    Rong H; Nianhua X; Jun X; Lianguo R; Si W; Sheng W; Heng G; Xia W
    AIDS Care; 2017 Dec; 29(12):1524-1528. PubMed ID: 28508665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reproductive choices in women living with HIV/AIDS in the era of highly active antiretroviral therapies (HAART)].
    Heard I; Sitta R; Lert F;
    Med Sci (Paris); 2008 Mar; 24 Spec No 2():48-52. PubMed ID: 18681120
    [No Abstract]   [Full Text] [Related]  

  • 33. Major depression in patients with HIV/AIDS and substance abuse.
    Berger-Greenstein JA; Cuevas CA; Brady SM; Trezza G; Richardson MA; Keane TM
    AIDS Patient Care STDS; 2007 Dec; 21(12):942-55. PubMed ID: 18154491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial.
    Barroso J; Bengtson AM; Gaynes BN; McGuinness T; Quinlivan EB; Ogle M; Heine A; Thielman NM; Pence BW
    AIDS Behav; 2016 Feb; 20(2):235-42. PubMed ID: 26525221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.
    Thomas CS; Bottiglieri T; Edeh J; Carney MW; Reynolds EH; Toone BK
    Int Clin Psychopharmacol; 1987 Apr; 2(2):97-102. PubMed ID: 3298421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerobic exercise training for depressive symptom management in adults living with HIV infection.
    Neidig JL; Smith BA; Brashers DE
    J Assoc Nurses AIDS Care; 2003; 14(2):30-40. PubMed ID: 12698764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-Adenosyl-Methionine improves depression in patients with Parkinson's disease in an open-label clinical trial.
    Di Rocco A; Rogers JD; Brown R; Werner P; Bottiglieri T
    Mov Disord; 2000 Nov; 15(6):1225-9. PubMed ID: 11104210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent depressive disorder among persons receiving an HIV test: an understudied phenomenon.
    Kagee A; Saal W
    AIDS Care; 2022 Dec; 34(12):1530-1533. PubMed ID: 35914113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV, antiretroviral therapy and suicidal behaviour: a multidisciplinary case report and underlying neuroimmunological pathways].
    Koolen F; Schippers JA; Oude Lashof AML; Leue C
    Tijdschr Psychiatr; 2019; 61(1):57-61. PubMed ID: 30640408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression and HIV/AIDS.
    Benton TD
    Curr Psychiatry Rep; 2008 Jun; 10(3):280-5. PubMed ID: 18652798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.